To determine if the MDs for first trimester PAPP-A and free β -hCG differed depending on timing of GDM diagnosis, we conducted a post-hoc stratified analysis in which pooled MDs were calculated separately for studies reporting biomarker MoM measurements for women who were diagnosed with GDM early and later in pregnancy. The gene discussed is PAPPA; the disease is gestational diabetes.